C-28 linker length modulates the activity of second-generation HIV-1 maturation inhibitors
Abstract Maturation inhibitors (MIs) block HIV-1 maturation by preventing the cleavage of the capsid protein and spacer peptide 1 (CA-SP1). Bevirimat (BVM), a first-in-class MI, displayed sub-optimal efficacy in clinical trials due to presence of SP1:V7A polymorphism in the Gag protein.This polymorp...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-01-01
|
| シリーズ: | Virology Journal |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12985-025-02635-8 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
